SRI Krishna Pharmaceuticals Limited
Indian Pharmaceutical Exporter ยท Analgesics & Antipyretics Specialist ยท $31.4M Total Trade ยท DGFT Verified
SRI Krishna Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $31.4M across 6 products in 3 therapeutic categories. Based on 705 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Paracetamol ($10.6M), Amino ($7.8M), Acetaminophen ($6.9M).
SRI Krishna Pharmaceuticals Limited โ Export Portfolio & Destination Treemap

Who is SRI Krishna Pharmaceuticals Limited? โ Company Overview & Market Position
Established on September 26, 1974, Sri Krishna Pharmaceuticals Limited (SKPL) is a prominent Indian pharmaceutical company headquartered in Hyderabad, Telangana. The company operates as a public limited entity, classified as a non-government company limited by shares, with a Corporate Identification Number (CIN) of U24230TG1974PLC001790. SKPL specializes in the bulk manufacture of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and finished dosage forms, including tablets, capsules, syrups, and injections.
As of the latest available data, the company has an authorized capital of โน150 million and a paid-up capital of โน119.185 million. While specific revenue figures are not publicly disclosed, SKPL has a workforce ranging from 501 to 1,000 employees, reflecting its substantial operational scale. The company's official website, www.srikrishnapharma.com, provides comprehensive information about its products, services, and regulatory certifications.